NCT07216482: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
- State
- Completed
- Phase
- Phase 3
- People
- 996 taking part
- Started
- 11 Nov 2025
- Primary completion
- 3 Aug 2026
- Arms
- Enlicitide, Enlicitide + Rosuvastatin
- Results
- None posted
- 14 Oct 2025: Trial registered
- 11 Nov 2025: Trial started
- 27 Oct 2026: Trial completed